Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Eli Lilly (NY:LLY)

769.88 +4.20 (+0.55%)
Official Closing Price Updated: 7:00 PM EDT, Jun 6, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Eli Lilly

< Previous 1 2
...
17 18 19 20 21 22 23 24 25
...
99 100 Next >
3 Stocks to Buy for 2025 That Are Practically Money Machines
Via The Motley Fool
Best Healthcare Stock to Buy: Eli Lilly vs. Novo Nordisk
Via The Motley Fool
This Promising New Alzheimer's Study Could Unlock a Massive Growth Opportunity for Novo Nordisk and Eli Lilly
Via The Motley Fool
Eli Lilly's Options: A Look at What the Big Money is Thinking
Via Benzinga
Investors Look Back at 2024
The S&P 500 had a great year. 
Via The Motley Fool
Topics Stocks
Exposures US Equities
Smart Money Is Betting Big In LLY Options
Via Benzinga
$100 Invested In Eli Lilly 15 Years Ago Would Be Worth This Much Today
Via Benzinga
Eli Lilly Unusual Options Activity
Via Benzinga
Viking Therapeutics, Structure Therapeutics Positioned As Key Pharma Partners For Weight Loss Products: Analyst
JPMorgan highlights valuation resets for Viking and Structure Therapeutics, citing opportunities in T2D/obesity and competitive clinical data insights. 
Via Benzinga
Israel Englander's Millennium Management Dumps Nvidia, Loads Up On Broadcom — Here's What The $70 Billion Hedge Fund Sees
Israel Englander's Millennium Management has made sweeping adjustments to its portfolio, including a remarkable 91,046.15% increase in Alibaba Group Holding Ltd. (NYSE:BABA) call options and a 94.69%... 
Via Benzinga
Prediction: These 3 Healthcare Stocks Will Soar in 2025
Via The Motley Fool
3 Trends To Watch
Hot topics for 2025 and why. 
Via Talk Markets
Topics Stocks / Equities
New Alphabet CFO Expected To Make Bigger Impact In 2025. Is Google Stock A Buy?
Google stock posted a big gain in 2024 but AI-driven competition in the internet search business and DoJ antitrust cases still loom. 
Via Investor's Business Daily
Is Eli Lilly Stock a Buy?
Via The Motley Fool
Jim Cramer Says Lazard Is 'Really Inexpensive,' Recommends Buying This Tech Stock
Via Benzinga
Eli Lilly Joins FDA Lawsuit Over Compounded Obesity Drugs, Seeks 'Swift End' And 'To Protect Its Interests'
Eli Lilly moves to defend FDA's tirzepatide shortage resolution amid criticism over supply issues and compounding pharmacy claims. 
Via Benzinga
Topics Lawsuit
Exposures Financial Legal Product Safety
Don't Buy Weight-Loss Medication From Unauthorized Sources, UK Health Agency Warns About Risks
The MHRA warns against buying weight-loss medicines illegally, emphasizing health risks and the need for prescriptions from licensed professionals to ensure safety. 
Via Benzinga
The 9 Best Stocks to Buy for 2025
Via The Motley Fool
US Employer Health Costs To Rise In 2025 Fueled By Weight Loss: Report
Eli Lilly's Zepbound is challenging Wegovy in the obesity market, while U.S. health care costs are set to rise 9% in 2025, driven by specialty drugs and inflation. 
Via Benzinga
EXCLUSIVE: Top 20 Most-Searched Tickers On Benzinga Pro In December 2024 — Where Do Tesla, Nvidia, Quantum Computing Stock Rank?
Each trading day features hundreds of headlines and press releases on Benzinga Pro, a source for traders to see the latest news on the overall market and individual tickers. 
Via Benzinga
Marjorie Taylor Greene Went Christmas Shopping For Stocks, Here's What She Bought Before Holiday
Marjorie Taylor Greene spent part of Christmas Eve buying stocks according to recent disclosures. Here's what she bought. 
Via Benzinga
Why 2024 Was Great for Stocks—and Why 2025 Could Be Even Better
Stocks soared in 2024, and 2025 could be even stronger. Let's look at key trends, government policies, and sectors poised for growth in the year ahead. 
Via MarketBeat
Topics Economy Energy
Exposures Economy Fossil Fuels Interest Rates
Pfizer: 4 Reasons to Buy This Stock
Pharmaceutical giant Pfizer Inc. (NYSE: PFE) stock is trading back down near its pandemic lows. Every time it attempts to climb over the $30 mark, something ca 
Via MarketBeat
Exposures COVID-19
Will This Major Pharmaceutical Stock Announce a Stock Split in 2025?
Via The Motley Fool
Billionaire Philippe Laffont Is Selling Artificial Intelligence Champion Nvidia and Piling Into These Two Industry Leaders
Via The Motley Fool
Topics Artificial Intelligence
Exposures Artificial Intelligence
2 Pharmaceutical Growth Stocks to Buy Now and Hold for Decades
Via The Motley Fool
Elon Musk Admits To Using Weight Loss Medication Criticized By RFK Jr, Says He Prefers Mounjaro Over Miracle Drug Ozempic
The world's richest man Elon Musk earlier this week admitted to using the weight loss drug Mounjaro. 
Via Benzinga
Prediction: This Will Be Amazon's Next Big Acquisition
Amazon may be known for its retail and tech chops, but the company has also built a strong operation in the healthcare realm over the last several years. 
Via The Motley Fool
Musk Tests Mounjaro, Ozempic, Wegovy: Which Weight-Loss Drug Won Him Over?
Elon Musk sparked conversation about weight-loss drugs and side effects with a Christmas social media post. 
Via Benzinga
Better Buy: Eli Lilly vs. Novo Nordisk. The Answer Is Becoming Abundantly More Clear.
Eli Lilly and Novo Nordisk are the two biggest names in the pharmaceutical sector, but I see one as the clear-cut winner for investors. 
Via The Motley Fool
< Previous 1 2
...
17 18 19 20 21 22 23 24 25
...
99 100 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.